Together
we can
Factor it
Forward

As just one person, alone, facing life’s challenges, the world can seem like an overwhelming place. That’s why the hemophilia B community is so important. It gives us strength.

Together, we become…

Factor It Forward can make a difference in the hemophilia B community, by providing factor to people with hemophilia B who truly need it.

Learn more about Factor It Forward.

0

Points earned for donations*

Goal: Points

Take
The Quiz

What Is Factor It Forward?

The people behind IXINITY® [coagulation factor IX (recombinant)] have partnered with AmeriCares, a non-profit global health organization, to donate IXINITY to people with hemophilia B who can’t afford to be without it.

As part of our commitment to the hemophilia B community, we donate 10% of our sales to those in need. Now we’re expanding the program to include activities for the entire community—so that we can all Factor It Forward.

This is the power of IX.

How Does It Work?

How you can get involved

For every 10 units of IXINITY used, 1 unit is donated to those in need. You can also Factor It Forward in the United States by earning points through our Giving Quiz, or by visiting one of our booths during a local hemophilia chapter education weekend. Our goal? Reach 100,000 points, which will translate to 100,000 units of factor donated to hemophilia camps.

Start the Quiz

How Hemophilia Centers can Enroll

For hemophilia treatment centers in the United States, it’s easy to Factor It Forward—by enrolling in the Factor It Forward network. The Factor It Forward partnership administers donated factor to enrolled centers for patients in need.

Enroll in Program

99,000

Points
Earned

What
Kind of
Giver Are
You?

What kind of giver are you? As generous as Mother Teresa or miserly as Scrooge? Find out how you stack up when it comes to going the extra mile for others. Take the Giving Quiz, and earn points that will contribute to factor donations.

Start Quiz

Learn More About IXINITY

Want to learn more about IXINITY, a recombinant factor IX for hemophilia B? Visit IXINITY.com.

Learn More

Important Safety Information


Indications and important safety information

What is IXINITY®?

IXINITY [coagulation factor IX (recombinant)] is a medicine used to replace clotting factor (factor IX) that is missing in adults and children at least 12 years of age with hemophilia B. Hemophilia B is also called congenital factor IX deficiency or Christmas disease. Hemophilia B is an inherited bleeding disorder that prevents clotting. Your healthcare provider may give you IXINITY to control and prevent bleeding episodes or when you have surgery.

IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B.

Important Safety Information for IXINITY®

  • You should not use IXINITY if you are allergic to hamsters or any ingredients in IXINITY.
  • You should tell your healthcare provider if you have or have had medical problems, take any medicines, including prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies, have any allergies, including allergies to hamsters, are nursing, are pregnant or planning to become pregnant, or have been told that you have inhibitors to factor IX.
  • You can experience an allergic reaction to IXINITY. Contact your healthcare provider or get emergency treatment right away if you develop a rash or hives, itching, tightness of the throat, chest pain, or tightness, difficulty breathing, lightheadedness, dizziness, nausea, or fainting.
  • Your body may form inhibitors to IXINITY. An inhibitor is part of the body's defense system. If you develop inhibitors, it may prevent IXINITY from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for development of inhibitors to IXINITY.
  • If you have risk factors for developing blood clots, the use of IXINITY may increase the risk of abnormal blood clots.
  • Call your healthcare provider right away about any side effects that bother you or do not go away, or if your bleeding does not stop after taking IXINITY.
  • The most common side effect that was reported with IXINITY during clinical trials was headache.
  • These are not all the side effects possible with IXINITY. You can ask your healthcare provider for information that is written for healthcare professionals.

Please see IXINITY full Prescribing Information, including important Patient Information.

You are encouraged to report side effects of prescription drugs to the Food and Drug Administration. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.